DX vs Insilico Medicine
Relationship
DX AI and Science42: DORA do comparable work on summarization; DX's scale not recorded.
Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.
5 of 6 capabilities — Shares agent orchestration, data analysis, evaluation and observability and 2 more.
Ludbee capability tags · from the product recordsShared product type — Both ship application.
Ludbee product recordsAligned comparison
Capability overlap
Shared · 5
Not verified for Insilico Medicine · 1
Recorded for DX. Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.
Not verified for DX · 3
Recorded for Insilico Medicine. DX’s product records say nothing either way — a missing record is not a missing capability.
Products, side by side
Algorithmic pairing — assembled from recorded fields, not hand-checked
DX
Application
DX AI is a conversational interface for exploring an organization's engineering data held in DX, described by the vendor as 'the copilot for engineering leaders.' It answers natural-language questions with generated charts, summarizes qualitative snapshot data into themes and sentiment, and diagnoses the drivers behind metric changes. Its data can also be streamed into external LLM clients via the DX MCP server.
Insilico Medicine
Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
No counterpart
DX sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.
API service
The DX MCP server exposes a customer's DX data to MCP-compatible AI clients such as Claude, Cursor and Devin Desktop. It is deliberately read-only, offering tools to list and retrieve software catalog entities, scorecards and initiatives, and teams, plus execution of SQL queries against the DX Data Cloud PostgreSQL database. It is available as a DX-hosted remote endpoint at ai.getdx.com/mcp or run locally from DX's open-source dx-mcp-server repository.
Developer tool
AI Code Insights measures what AI coding agents produce inside an engineering organization, tracking AI-generated code by commit, PR, team, agent and repo from IDE to production. It attributes authorship by monitoring supported coding agents' edits and links them to commits, pull requests and deployments, reporting adoption, delivery velocity, code-quality signals and session-level agent performance. It includes the Agent Experience report, which scores requirements clarity, steering and task scope from the agent's perspective.
Command-line interface to a DX instance, built so coding agents can drive it: it ships an agent skill telling an agent when and how to call the CLI, and covers the same catalog, scorecard and self-service operations a human uses the dashboard for.
Fabric is DX's context layer for AI agents, marketed as 'the context engine for AI-native engineering.' It turns an organization's software catalog into structured, live context that agents can query, and adds scorecards and self-service automation so agents can create services, provision infrastructure and resolve failing standards checks. Context is exposed to any MCP-compatible agent via the DX MCP server.
Insilico Medicine sells these in a stack layer with no product recorded for DX yet — nothing on the other side to compare them against.
Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.